Eiko Lifesciences Ltd — Results, 14-05-2025: Result

Eiko LifeSciences Limited has announced a board meeting outcome, approving the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, with an unmodified audit opinion from PSV Jain & Associates. Consolidated revenue stood at INR 37.66 Cr with a profit before tax of INR 3.06 Cr, driven by Specialty & Fine Chemicals and newly commenced Logistics business segments. The company appointed M/s Shravan Gupta & Associates as Secretarial Auditor for five years and M/s NP Rajput & Co. as Internal Auditor for FY 2025-26. Exceptional income includes 34.12 lakhs from interest on delayed call money payments from shareholders.